OBJECTIVE: Neutrophils represent a prominent component of inflammatory joint effusions and are required for synovial inflammation in mouse models, but the mechanisms are poorly understood. In this study, we developed a system with which to test the importance of the production of specific factors by neutrophils in a mouse model of arthritis. METHODS: Neutrophil-deficient Gfi-1(-/-) mice were administered sublethal doses of radiation and were then engrafted with donor bone marrow cells (BMCs), which resulted in the production of mature neutrophils within 2 weeks. By reconstituting with BMCs from mice lacking selected proinflammatory factors, we generated mice that specifically lacked these factors on their neutrophils. Arthritis was initiated by transfer of K/BxN serum to identify the role of defined neutrophil factors on the incidence and severity of arthritis. RESULTS: Neutrophils lacking the signaling chain of stimulatory Fc receptors (FcRgamma(-/-)) were unable to elicit arthritis, but neutrophils lacking FcgammaRIII still did so. Neutrophils lacking the chemotactic or adhesion receptor C5a receptor (C5aR) or CD11a/lymphocyte function-associated antigen 1 (LFA-1) also failed to initiate arthritis but could enter joints in which inflammation had been initiated by wild-type neutrophils. Neutrophils unable to produce interleukin-1alpha (IL-1alpha) and IL-1beta (IL-1alpha/beta(-/-)) or leukotrienes (5-lipoxygenase [5-LOX(-/-)]) produced arthritis of intermediate severity. The inability of neutrophils to make tumor necrosis factor or to express receptors for tumor necrosis factor or IL-1 had no effect on arthritis. CONCLUSION: A novel transfer system was developed to identify neutrophil production of FcRgamma, C5aR, and CD11a/LFA-1 as critical components of autoantibody-mediated arthritis. Neutrophil production of IL-1 and leukotriene B(4) likely contributes to inflammation but is not essential. Molecular requirements for neutrophil influx into joints become more permissive after inflammation is initiated.
OBJECTIVE: Neutrophils represent a prominent component of inflammatory joint effusions and are required for synovial inflammation in mouse models, but the mechanisms are poorly understood. In this study, we developed a system with which to test the importance of the production of specific factors by neutrophils in a mouse model of arthritis. METHODS: Neutrophil-deficient Gfi-1(-/-) mice were administered sublethal doses of radiation and were then engrafted with donor bone marrow cells (BMCs), which resulted in the production of mature neutrophils within 2 weeks. By reconstituting with BMCs from mice lacking selected proinflammatory factors, we generated mice that specifically lacked these factors on their neutrophils. Arthritis was initiated by transfer of K/BxN serum to identify the role of defined neutrophil factors on the incidence and severity of arthritis. RESULTS: Neutrophils lacking the signaling chain of stimulatory Fc receptors (FcRgamma(-/-)) were unable to elicit arthritis, but neutrophils lacking FcgammaRIII still did so. Neutrophils lacking the chemotactic or adhesion receptor C5a receptor (C5aR) or CD11a/lymphocyte function-associated antigen 1 (LFA-1) also failed to initiate arthritis but could enter joints in which inflammation had been initiated by wild-type neutrophils. Neutrophils unable to produce interleukin-1alpha (IL-1alpha) and IL-1beta (IL-1alpha/beta(-/-)) or leukotrienes (5-lipoxygenase [5-LOX(-/-)]) produced arthritis of intermediate severity. The inability of neutrophils to make tumor necrosis factor or to express receptors for tumor necrosis factor or IL-1 had no effect on arthritis. CONCLUSION: A novel transfer system was developed to identify neutrophil production of FcRgamma, C5aR, and CD11a/LFA-1 as critical components of autoantibody-mediated arthritis. Neutrophil production of IL-1 and leukotriene B(4) likely contributes to inflammation but is not essential. Molecular requirements for neutrophil influx into joints become more permissive after inflammation is initiated.
Authors: Niels C Riedemann; Ren-Feng Guo; Hongwei Gao; Lei Sun; Marco Hoesel; Travis J Hollmann; Rick A Wetsel; Firas S Zetoune; Peter A Ward Journal: J Immunol Date: 2004-07-15 Impact factor: 5.422
Authors: Estelle Merck; Claude Gaillard; Daniel M Gorman; Felix Montero-Julian; Isabelle Durand; Sandra M Zurawski; Christine Menetrier-Caux; Giuseppe Carra; Serge Lebecque; Giorgio Trinchieri; Elizabeth E M Bates Journal: Blood Date: 2004-05-20 Impact factor: 22.113
Authors: Jun-Xia Wang; Angela M Bair; Sandra L King; Ruslan Shnayder; Ya-Fang Huang; Chi-Chang Shieh; Roy J Soberman; Robert C Fuhlbrigge; Peter A Nigrovic Journal: Blood Date: 2012-06-01 Impact factor: 22.113
Authors: Patricia Y Tsao; Vaishali Arora; Mei Qing Ji; Alexander C Wright; Robert A Eisenberg Journal: J Clin Immunol Date: 2011-07-06 Impact factor: 8.317
Authors: Antonina Akk; Luke E Springer; Lihua Yang; Samantha Hamilton-Burdess; John D Lambris; Huimin Yan; Ying Hu; Xiaobo Wu; Dennis E Hourcade; Mark J Miller; Christine T N Pham Journal: Mol Immunol Date: 2019-09-19 Impact factor: 4.407
Authors: Qi-Quan Huang; Renee E Koessler; Robert Birkett; Harris Perlman; Lianping Xing; Richard M Pope Journal: J Leukoc Biol Date: 2013-02-27 Impact factor: 4.962
Authors: Christoph Kessel; Kutty S Nandakumar; Francis B Peters; Varun Gauba; Peter G Schultz; Rikard Holmdahl Journal: Arthritis Rheumatol Date: 2014-03 Impact factor: 10.995